annual CFF:
$139.42M-$79.33M(-36.26%)Summary
- As of today (September 16, 2025), TVTX annual cash flow from financing activities is $139.42 million, with the most recent change of -$79.33 million (-36.26%) on December 31, 2024.
- During the last 3 years, TVTX annual CFF has fallen by -$92.26 million (-39.82%).
- TVTX annual CFF is now -39.87% below its all-time high of $231.86 million, reached on December 31, 2018.
Performance
TVTX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.48M-$2.24M(-60.33%)Summary
- As of today (September 16, 2025), TVTX quarterly cash flow from financing activities is $1.48 million, with the most recent change of -$2.24 million (-60.33%) on June 30, 2025.
- Over the past year, TVTX quarterly CFF has increased by +$693.00 thousand (+88.62%).
- TVTX quarterly CFF is now -99.36% below its all-time high of $230.96 million, reached on September 30, 2018.
Performance
TVTX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$144.36M+$693.00K(+0.48%)Summary
- As of today (September 16, 2025), TVTX TTM cash flow from financing activities is $144.36 million, with the most recent change of +$693.00 thousand (+0.48%) on June 30, 2025.
- Over the past year, TVTX TTM CFF has increased by +$144.61 million (+57158.50%).
- TVTX TTM CFF is now -56.15% below its all-time high of $329.24 million, reached on March 31, 2021.
Performance
TVTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TVTX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.3% | +88.6% | +10000.0% |
| 3 y3 years | -39.8% | +77.5% | -4.0% |
| 5 y5 years | +6812.7% | -98.6% | +41.0% |
TVTX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.8% | +18.6% | -99.3% | +332.6% | -35.0% | >+9999.0% |
| 5 y | 5-year | -39.8% | +6812.7% | -99.3% | +332.6% | -56.1% | >+9999.0% |
| alltime | all time | -39.9% | +2548.6% | -99.4% | +103.7% | -56.1% | +441.2% |
TVTX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.48M(-60.3%) | $144.36M(+0.5%) |
| Mar 2025 | - | $3.72M(-97.3%) | $143.66M(+3.0%) |
| Dec 2024 | $139.42M(-36.3%) | $139.12M(>+9900.0%) | $139.42M(>+9900.0%) |
| Sep 2024 | - | $46.00K(-94.1%) | $427.00K(-268.8%) |
| Jun 2024 | - | $782.00K(-249.0%) | -$253.00K(-120.6%) |
| Mar 2024 | - | -$525.00K(-523.4%) | $1.23M(-99.4%) |
| Dec 2023 | $218.75M(+86.1%) | $124.00K(-119.6%) | $218.75M(-0.2%) |
| Sep 2023 | - | -$634.00K(-128.0%) | $219.18M(-1.3%) |
| Jun 2023 | - | $2.27M(-99.0%) | $222.09M(+0.7%) |
| Mar 2023 | - | $217.00M(>+9900.0%) | $220.66M(+87.7%) |
| Dec 2022 | $117.57M(-49.3%) | $551.00K(-75.8%) | $117.57M(-21.7%) |
| Sep 2022 | - | $2.28M(+174.1%) | $150.24M(-0.1%) |
| Jun 2022 | - | $831.00K(-99.3%) | $150.37M(+0.4%) |
| Mar 2022 | - | $113.91M(+243.0%) | $149.84M(-35.3%) |
| Dec 2021 | $231.68M(+81.4%) | $33.21M(+1275.8%) | $231.68M(+3.7%) |
| Sep 2021 | - | $2.41M(+696.7%) | $223.51M(+1.3%) |
| Jun 2021 | - | $303.00K(-99.8%) | $220.75M(-33.0%) |
| Mar 2021 | - | $195.75M(+681.8%) | $329.24M(+157.8%) |
| Dec 2020 | $127.71M(-6248.9%) | $25.04M(-7295.1%) | $127.71M(+24.3%) |
| Sep 2020 | - | -$348.00K(-100.3%) | $102.77M(+0.4%) |
| Jun 2020 | - | $108.80M(-1984.5%) | $102.38M(-1619.0%) |
| Mar 2020 | - | -$5.77M(-6176.8%) | -$6.74M(+224.5%) |
| Dec 2019 | -$2.08M(-100.9%) | $95.00K(-112.9%) | -$2.08M(+26.1%) |
| Sep 2019 | - | -$738.00K(+127.8%) | -$1.65M(-100.7%) |
| Jun 2019 | - | -$324.00K(-70.8%) | $230.05M(-1.5%) |
| Mar 2019 | - | -$1.11M(-311.4%) | $233.46M(+0.7%) |
| Dec 2018 | $231.86M(+4158.3%) | $525.00K(-99.8%) | $231.86M(-0.4%) |
| Sep 2018 | - | $230.96M(+7386.4%) | $232.70M(+2970.3%) |
| Jun 2018 | - | $3.08M(-214.2%) | $7.58M(+144.2%) |
| Mar 2018 | - | -$2.70M(-298.5%) | $3.10M(-43.0%) |
| Dec 2017 | $5.45M | $1.36M(-76.7%) | $5.45M(-294.1%) |
| Sep 2017 | - | $5.83M(-519.8%) | -$2.81M(-39.0%) |
| Jun 2017 | - | -$1.39M(+285.0%) | -$4.60M(-10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$361.00K(-94.8%) | -$5.13M(-9.9%) |
| Dec 2016 | -$5.69M(-105.7%) | -$6.89M(-270.6%) | -$5.69M(-499.9%) |
| Sep 2016 | - | $4.04M(-310.6%) | $1.42M(-103.4%) |
| Jun 2016 | - | -$1.92M(+107.0%) | -$42.31M(+7.6%) |
| Mar 2016 | - | -$926.00K(-504.4%) | -$39.33M(-139.0%) |
| Dec 2015 | $100.77M(+5.7%) | $229.00K(-100.6%) | $100.77M(+0.8%) |
| Sep 2015 | - | -$39.70M(-3803.7%) | $100.00M(-30.2%) |
| Jun 2015 | - | $1.07M(-99.2%) | $143.25M(-26.9%) |
| Mar 2015 | - | $139.17M(<-9900.0%) | $195.87M(+105.5%) |
| Dec 2014 | $95.32M(+228.9%) | -$534.00K(-115.1%) | $95.32M(-0.0%) |
| Sep 2014 | - | $3.54M(-93.4%) | $95.32M(-15.6%) |
| Jun 2014 | - | $53.69M(+39.0%) | $112.91M(+90.7%) |
| Mar 2014 | - | $38.62M(-7388.9%) | $59.22M(+104.3%) |
| Dec 2013 | $28.98M(+553.1%) | -$529.80K(-102.5%) | $28.98M(-1.8%) |
| Sep 2013 | - | $21.13M(>+9900.0%) | $29.51M(+252.3%) |
| Jun 2013 | - | $0.00(-100.0%) | $8.38M(0.0%) |
| Mar 2013 | - | $8.38M(>+9900.0%) | $8.38M(>+9900.0%) |
| Dec 2012 | $4.44M(>+9900.0%) | - | - |
| Nov 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2009 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Feb 2009 | $25.00K(>+9900.0%) | $0.00(0.0%) | $25.00K(0.0%) |
| Nov 2008 | - | $0.00(0.0%) | $25.00K(0.0%) |
| Aug 2008 | - | $0.00(-100.0%) | $25.00K(0.0%) |
| May 2008 | - | $25.00K | $25.00K |
| Feb 2008 | $0.00 | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual CFF year-on-year change?
- What is Travere Therapeutics, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly CFF year-on-year change?
- What is Travere Therapeutics, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM CFF year-on-year change?
What is Travere Therapeutics, Inc. annual cash flow from financing activities?
The current annual CFF of TVTX is $139.42M
What is the all time high annual CFF for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual cash flow from financing activities is $231.86M
What is Travere Therapeutics, Inc. annual CFF year-on-year change?
Over the past year, TVTX annual cash flow from financing activities has changed by -$79.33M (-36.26%)
What is Travere Therapeutics, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of TVTX is $1.48M
What is the all time high quarterly CFF for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $230.96M
What is Travere Therapeutics, Inc. quarterly CFF year-on-year change?
Over the past year, TVTX quarterly cash flow from financing activities has changed by +$693.00K (+88.62%)
What is Travere Therapeutics, Inc. TTM cash flow from financing activities?
The current TTM CFF of TVTX is $144.36M
What is the all time high TTM CFF for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM cash flow from financing activities is $329.24M
What is Travere Therapeutics, Inc. TTM CFF year-on-year change?
Over the past year, TVTX TTM cash flow from financing activities has changed by +$144.61M (+57158.50%)